Miguel A. Reséndiz Gachús

Mr. Miguel A. Reséndiz Gachús

orcid

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 August 2025 in Cells
Verified
Journal Article
Open access
PDF file
AMArmida Miranda
Armida Miranda
REROSA ESTRADA-REYES
ROSA ESTRADA-REYES
LCLuis Alejandro Constantino-Jonapa
Luis Alejandro Constantino-Jonapa
JAJesús Argueta
Jesús Argueta
JOJulián Oikawa-Sala
Julián Oikawa-Sala
GBGloria NACIONAL DE PSIQUIATRIA RAMON DE LA FUENTE Benítez-King
Gloria NACIONAL DE PSIQUIATRIA RAMON DE LA FUENTE Benítez-King
Forty per cent of major depression patients are resistant to antidepressant medication. Thus, it is necessary to search for alternative treatments. Melatonin (N-acetyl-5-hydroxytryptamine) enhances neurogenesis and neuronal survival in the adult mouse hippocampal dentate gyrus. Additionally, melatonin stimulates the activity of Ca2+/Calmodulin-dependent Kinase II (CaMKII), promoting dendrite formation and neurogenic processes in human olfactory neuronal precursors and rat organotypic cultures. Similarly, ketamine, an N-methyl-D-aspartate receptor (NMDAR) antagonist, modulates CaMKII activity. Importantly, co-treatment of low doses of ketamine (10−7 M) in combination with melatonin (10−7 M) produces additive effects on neurogenic responses in olfactory neuronal precursors. Importantly, enhanced neurogenic responses are produced by conventional antidepressants like ISSRs. The goal of this study was to investigate whether hippocampal CaMKII participates in the signaling pathway elicited by combining doses of melatonin with ketamine acutely administered to mice, 30 min before being subjected to the forced swimming test. The results showed that melatonin, in conjunction with ketamine, significantly enhances CaMKII activation and changes its subcellular distribution in the dentate gyrus of the hippocampus. Remarkably, melatonin causes nuclear translocation of the active form of CaMKII. Luzindole, a non-selective MT1 and MT2 receptor antagonist, abolished these effects, suggesting that CaMKII is downstream of the melatonin receptor pathway that causes the antidepressant-like effects. These findings provide molecular insights into the combined effects of melatonin and ketamine on neuronal plasticity-related signaling pathways and pave the way for combating depression using combination therapy.

18 August 2025 in Preprints.org
Verified
Preprint
Open access
PDF file
SASalvador Alarcon-Elizalde
Salvador Alarcon-Elizalde
ALAlejandra Lora-Castellanos
Alejandra Lora-Castellanos
VSValeria Santillan-Morales
Valeria Santillan-Morales
MGMiguel A. Reséndiz Gachús
Miguel A. Reséndiz Gachús
RERosa Estrada-Reyes
Rosa Estrada-Reyes
GBGloria Acacia Benítez-King
Gloria Acacia Benítez-King
Smell dysfunction affects quality of life and is considered an early clinical sign of Alzheimer’s and Parkinson’s diseases. Olfactory loss increases with age and is associated with certain ciliopathies, a group of genetic disorders characterized by a wide spectrum of multisystemic disturbances. The dysfunction of mature olfactory sensory neurons (OSNs) in the olfactory neuronal pathway remains poorly understood. Previous evidence suggests that primary cilia proteins are involved in the maturation of olfactory sensory neurons (OSNs). In this study, we obtained olfactory neuronal precursors (ONPs) from the olfactory mucosa of young and older healthy volunteers who reported smell impairment (hyposmia) without neurological deficits or underlying airflow issues (conductive olfactory loss), and from normosmic individuals. In vitro analysis of ONPs showed that these cells can form primary cilia in normosmic individuals, while in hyposmic participants, there is a reduction in cilia frequency and a shorter length. In addition, ONPs from hyposmic individuals had a decrease in proliferation and cell differentiation. Our data indicates that alterations in molecular pathways related to primary cilia formation and the proliferation of ONPs lead to defects in neuronal maturation. These changes may hinder the differentiation of olfactory sensory neurons OSNs and contribute, at least in part, to olfactory loss.

Verified
Journal Article
Open access
PDF file
SASalvador Alarcon-Elizalde
Salvador Alarcon-Elizalde
ALAlejandra Lora-Castellanos
Alejandra Lora-Castellanos
VSValeria Santillán-Morales
Valeria Santillán-Morales
MGMiguel A. Reséndiz Gachús
Miguel A. Reséndiz Gachús
REROSA ESTRADA-REYES
ROSA ESTRADA-REYES
GBGloria NACIONAL DE PSIQUIATRIA RAMON DE LA FUENTE Benítez-King
Gloria NACIONAL DE PSIQUIATRIA RAMON DE LA FUENTE Benítez-King
Smell dysfunction affects quality of life and is considered an early clinical sign of Alzheimer’s and Parkinson’s diseases. Olfactory loss increases with age and is associated with certain ciliopathies, a group of genetic disorders characterized by a wide spectrum of multisystemic disturbances. The dysfunction of mature olfactory sensory neurons (OSNs) in the olfactory neuronal pathway remains poorly understood. Previous evidence suggests that primary cilia proteins are involved in the maturation of olfactory sensory neurons (OSNs). In this study, we obtained olfactory neuronal precursors (ONPs) from the olfactory mucosa of young and older healthy volunteers who reported smell impairment (hyposmia) without neurological deficits or underlying airflow issues (conductive olfactory loss) and from normosmic individuals. In vitro analysis of ONPs showed that these cells can form primary cilia in normosmic individuals, while in hyposmic participants, there is a reduction in cilia frequency and a shorter length. In addition, ONPs from hyposmic individuals had a decrease in proliferation and cell differentiation. Our data indicate that alterations in molecular pathways related to primary cilia formation and the proliferation of ONPs lead to defects in neuronal maturation. These changes may hinder the differentiation of olfactory sensory neurons OSNs and contribute, at least in part, to olfactory loss.